ASA: Fibrinogen-to-Albumin Ratio Is Risk Factor for Preeclampsia

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 24, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 24, 2024 -- The fibrinogen-to-albumin ratio (FAR) is an independent risk factor for development of any preeclampsia (PE) and PE with severe features (sPE), according to a study presented at the annual meeting of the American Society of Anesthesiologists, held from Oct. 18 to 22 in Philadelphia.

Lucy Shang, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined whether serum levels of albumin (Alb), fibrinogen (Fib), and FAR are associated with PE and its severity. Data were included for 2,629 women who gave birth between 2018 and 2024: 1,819 control women, 584 with PE with mild features (mPE), and 226 with sPE.

The researchers found no significant differences in gravidity in the three groups. Fib, FAR, hemoglobin (Hgb), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were independent risk factors for the development of any PE (odds ratios, 1.20, 68.48, 0.90, 3.93, and 3.65, respectively). For sPE, only FAR was an independent risk factor (odds ratio, 18.49). FAR was one of two markers that were significant in predicting both any PE and sPE (odds ratios, 32.77 and 11.22, respectively) in multivariable logistic regression adjusting for confounders, including Hgb, ALT, AST, age, race, and gravidity, and multiple gestations. FAR had the highest area under the curve value of 0.546 compared with all other markers in a receiver operating curve analysis.

"Additional research is needed to determine the exact range of the FAR that would be considered concerning and would be helpful to incorporate into routine prenatal care as a predictive tool for early identification of preeclampsia," Shang said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords